Join us while we dive deep into the following points:

• How do you solve the problem about varying follow-up times?
• What’s so special about the setup of the SAVVY collaboration?
• Where can people learn more about SAVVY?

• Stegherr et al (2021) Biom J  https://doi.org/10.1002/bimj.201900347
• Preprint https://arxiv.org/abs/2001.05709
• One-sample case: https://arxiv.org/abs/2008.07883
• Two-sample case: https://arxiv.org/abs/2008.07881
• Example R code (markdown file): https://numbersman77.github.io/AEprobs/SAVVY_AEprobs.html
• "Special Issue:Analysis of Adverse Event Data"
• Van Walraven
• see also Letter
• Related paper on: "On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies"
• Working Savvy